Replaced site | Stanford type | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute | Chronic | Concomitant operation | Redo | ||||||||||||||||||||||
A | B | A | B | ||||||||||||||||||||||
Cases | 30-day mortality | Hospital mortality | Cases | 30-day mortality | Hospital mortality | Cases | 30-day mortality | Hospital mortality | Cases | 30-day mortality | Hospital mortality | AVP | AVR | MVP | MVR | CABG | Cases | 30-day mortality | Hospital mortality | ||||||
Hospital | After discharge | Hospital | After discharge | Hospital | After discharge | Hospital | After discharge | Hospital | After discharge | ||||||||||||||||
1. Ascending Ao. | 2,447 | 190 (7.8) | 2 (0.1) | 232 (9.5) | 3 | 1 (33.3) | 0 | 1 (33.3) | 222 | 5 (2.3) | 0 | 6 (2.7) | 8 | 1 (12.5) | 0 | 1 (12.5) | 240 | 134 | 17 | 10 | 125 | 49 | 8 (16.3) | 0 | 8 (16.3) |
2. Aortic Root | 149 | 28 (18.8) | 0 | 33 (22.1) | 0 | 0 | 0 | 0 | 68 | 7 (10.3) | 0 | 9 (13.2) | 4 | 0 | 0 | 0 | 21 | 118 | 5 | 1 | 42 | 48 | 9 (18.8) | 0 | 11 (22.9) |
3. Ascending Ao.+Arch | 1,340 | 116 (8.7) | 2 (0.15) | 150 (11.2) | 16 | 3 (18.8) | 0 | 3 (18.8) | 302 | 8 (2.6) | 1 (0.3) | 18 (6.0) | 107 | 4 (3.7) | 0 | 9 (8.4) | 112 | 61 | 10 | 3 | 87 | 90 | 4 (4.4) | 0 | 5 (5.6) |
4. Arch+Descending Ao. | 30 | 4 (13.3) | 0 | 4 (13.3) | 10 | 4 (40.0) | 0 | 5 (50.0) | 21 | 1 (4.8) | 0 | 1 (4.8) | 79 | 6 (7.6) | 0 | 9 (11.4) | 0 | 1 | 0 | 0 | 5 | 9 | 1 (11.1) | 0 | 2 (22.2) |
5. Aortic Root+Asc.Ao.+Arch | 96 | 21 (21.9) | 1 (1.0) | 22 (22.9) | 0 | 0 | 0 | 0 | 27 | 0 | 0 | 0 (0.0) | 4 | 0 | 0 | 0 | 18 | 51 | 0 | 1 | 13 | 10 | 0 | 0 | 0 |
6. Descending Ao. | 11 | 0 | 0 | 1 (9.1) | 52 | 8 (15.4) | 0 | 11 (21.2) | 77 | 4 (5.2) | 0 | 6 (7.8) | 217 | 8 (3.7) | 0 | 14 (6.5) | 1 | 4 | 0 | 0 | 4 | 38 | 6 (15.8) | 0 | 7 (18.4) |
7. Thoracoabdominal Ao. | 5 | 0 | 0 | 0 | 12 | 1 (8.3) | 0 | 2 (16.7) | 49 | 3 (6.1) | 0 | 3 (6.1) | 151 | 13 (8.6) | 0 | 16 (10.6) | 0 | 0 | 0 | 0 | 0 | 43 | 4 (9.3) | 0 | 4 (9.3) |
8. Extra-anatomical bypass | 11 | 0 | 0 | 1 (9.1) | 19 | 1 (5.3) | 0 | 2 (10.5) | 4 | 0 | 0 | 0 (0.0) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
9. Stent graft*a | 97 | 1 (1.0) | 0 | 1 (1.0) | 120 | 6 (5.0) | 0 | 8 (6.7) | 100 | 3 (3.0) | 0 | 5 (5.0) | 518 | 8 (1.5) | 0 | 15 (2.9) | 5 | 3 | 0 | 0 | 5 | 99 | 2 (2.0) | 0 | 3 (3.0) |
1) TEVARl*b | 35 | 1 (2.9) | 0 | 1 (2.9) | 110 | 6 (5.5) | 0 | 8 (7.3) | 86 | 3 (3.5) | 0 | 5 (5.8) | 492 | 7 (1.4) | 0 | 13 (2.6) | 2 | 0 | 0 | 0 | 0 | 97 | 2 (2.1) | 0 | 3 (3.1) |
2) Open stent | 62 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 23 | 1 (4.3) | 0 | 2 (8.7) | 3 | 3 | 0 | 0 | 5 | 2 | 0 | 0 | 0 |
a) With total arch*c | 3 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
b) Without total arch*d | 59 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 13 | 0 | 0 | 0 | 19 | 1 (5.3) | 0 | 2 (10.5) | 2 | 3 | 0 | 0 | 5 | 1 | 0 | 0 | 0 |
3) Unspecified | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4,186 | 360 | 5 (0.12) | 444 (10.6) | 232 | 24 (10.3) | 0 | 32 (13.8) | 870 | 31 (3.6) | 1 (0.1) | 48 (5.5) | 1,092 | 40 (3.7) | 0 | 64 (5.9) | 397 | 372 | 32 | 15 | 281 | 386 | 34 (8.8) | 0 | 40 (10.4) |
Values in parenthesis represent mortality %
Ao aorta, AVP aortic valve repair, AVR aortic valve replacement, MVP mitral valve repair, MVR mitral valve replacement, CABG coronary artery bypass grafting, TEVAR thoracic endovascular aortic(aneurysm) repair
Acute, within 2 weeks from the onset
*a = *b + *c + *d + unspecified